Item Number | Policy/Procedure | Date Posted | Comment Period Closed | Status | Document Links | |
---|---|---|---|---|---|---|
2021-ABH-1169 | Provider Appeals Policy | 12/23/21 | 2/6/22 | Approved | Provider Appeals Policy | |
2021-ABH-1176 | Act 421 Policy | 12/22/21 | 2/5/22 | Approved | Act 421 Policy | |
2021-LDH-17 | MCO Manual > Part 4: Services > Pharmacy > Brand Name and Generic Drugs (Proposed effective date = 3/13/2022) | 12/22/21 | 2/5/22 | Completed | MCO Manual > Pharmacy Brand Name & Generic Drugs | |
2021-LDH-16 | MCO Manual > Part 4: Services > Ambulatory Surgical Services > Outpatient Hospital Ambulatory Surgery (Proposed effective date = 3/13/2022) | 12/22/21 | 2/5/22 | Completed | MCO Manual > Outpatient Hospital Ambulatory Surgery | |
2021-LDH-15 | MCO Manual > Part 4: Services > Professional Services > Sinus Procedures (Proposed effective date = 3/6/2022) | 12/14/21 | 1/28/22 | Completed | MCO Manual > Part 4: Services > Professional Services > Sinus Procedures (Proposed effective date = 3/6/2022) | |
2021-ABH-940 | Policy for Applied Behavioral Health | 12/3/21 | 1/17/22 | Pending | Policy for Applied Behavioral Health | |
2021-ABH-939 | Peer Support Services | 12/3/21 | 1/17/22 | Pending | Peer Support Services | |
2021-HBL-602 | Psychiatric Support and Treatment | 12/2/21 | 1/16/22 | Pending | Psychiatric Support and Treatment | |
2021-UHC-1167 | Prostate Surgeries and Interventions | 12/2/21 | 1/16/22 | Pending | Prostate Surgeries and Interventions | |
2021-ACLA-1177 | Potential Upcoding of Surgical Services | 12/22/21 | 2/5/22 | Denied | Potential Upcoding of Surgical Services | |
2021-LHCC-1168 | Allergy Testing and Therapy | 11/29/21 | 1/13/22 | Pending | Allergy Testing and Therapy | |
2021-UHC-1166 | C & S Utilization Management of BH Benefits Addendum | 11/23/21 | 1/7/22 | Pending | C & S Utilization Management of BH Benefits Addendum | |
2021-HBL-601 | Hyperthermia for Cancer Therapy | 11/22/21 | 1/6/22 | Pending | Hyperthermia for Cancer Therapy | |
2021-LDH-14 | MCO Manual > Part 4: Services > Professional Services > Cardiovascular Services (Proposed effective date = 1/26/2022) | 11/3/2021 | 12/18/2021 | Completed | MCO Manual > Part 4: Services > Professional Services > Cardiovascular Services | |
2021-LDH-13 | MCO Manual > Part 4: Services > Professional Services > Cochlear Implant (Proposed effective date = 1/26/2022) MCO Manual > Part 4: Services > Professional Services > Cochlear Implant (Proposed effective date = 1/26/2022) | 11/3/2021 | 12/18/2021 | Completed | MCO Manual > Part 4: Services > Professional Services > Cochlear Implant | |
2021-HBL-1165 | Psychological testing and Neuropsychological Testing | 11/2/21 | 12/17/21 | Approved | Psychological testing and Neuropsychological Testing | |
2021-HBL-1164 | Serum Biomarker Tests for Risk of Preeclampsia | 11/2/21 | 12/17/21 | Approved | Serum Biomarker Tests for Risk of Preeclampsia | |
2021-HBL-1163 | TruGraf Blood Gene Exp Test for Trans Monit | 11/2/21 | 12/17/21 | Approved | TruGraf Blood Gene Exp Test for Trans Monit | |
2021-HBL-1162 | Substance Use Disorders-Residential Treatment | 11/2/21 | 12/17/21 | Approved | Substance Use Disorders-Residential Treatment | |
2021-HBL-1154 | Pre-certification of Requested Services | 11/2/21 | 12/17/21 | Approved | Pre-certification of Requested Services | |
2021-ABH-938 | Sterilization Policy | 11/2/21 | 12/17/21 | Approved | Steilization Policy | |
2021-HBL-1031 | Modifier 26 and TC: Professional and Technical Component | 10/25/21 | 12/9/21 | Approved | Modifier 26 and TC: Professional and Technical Component | |
2021-HBL-1048 | Intracardiac Electrophysiological Studies | 10/25/21 | 12/9/21 | Approved | Intracardiac Electrophysiological Studies | |
2021-HBL-1149 | Colonoscopy | 10/25/21 | 12/9/21 | Approved | Colonoscopy | |
2021-HBL-1150 | Cardiac Stress Testing with Electrocardiogram | 10/25/21 | 12/9/21 | Approved | Cardiac Stress Testing with Electrocardiogram | |
2021-HBL-1151 | Intracytoplasmic Sperm Injection | 10/25/21 | 12/9/21 | Approved | Intracytoplasmic Sperm Injection | |
2021-HBL-1152 | Functional Endoscopic Sinus Surgery | 10/25/21 | 12/9/21 | Approved | Functional Endoscopic Sinus Surgery | |
2021-HBL-1153 | Vagus Nervous Stimulator | 10/25/21 | 12/9/21 | Approved | Vagus Nervous Stimulator | |
2021-HBL-1155 | Home Parenteral Nutrition | 10/25/21 | 12/9/21 | Approved | Home Parenteral Nutrition | |
2021-HBL-1156 | Eye Move Analysis Using Non-spatial Calib for the Diag of Concussion | 10/25/21 | 12/9/21 | Approved | Eye Move Analysis Using Non-spatial Calib for the Diag of Concussion | |
2021-HBL-1157 | Open Sacroiliac Joint Fusion | 10/25/21 | 12/9/21 | Approved | Open Sacroiliac Joint Fusion | |
2021-HBL-1158 | Site of Care: Advanced Radiologic Imaging | 10/25/21 | 12/9/21 | Approved | Site of Care: Advanced Radiologic Imaging | |
2021-HBL-1159 | Endobronchial Valve Devices | 10/25/21 | 12/9/21 | Approved | Endobronchial Valve Devices | |
2021-HBL-1160 | Microprocessor Controlled Knee-Ankle-Foot Orthosis | 10/25/21 | 12/9/21 | Approved | Microprocessor Controlled Knee-Ankle-Foot Orthosis | |
2021-HBL-1161 | Tonsillectomy with or without Adenoidectomy for Adults | 10/25/21 | 12/9/21 | Approved | Tonsillectomy with or without Adenoidectomy for Adults | |
2021-HBL-1162 | Substance Use Disorders-Residential Treatment | 10/25/21 | 12/9/21 | Approved | Substance Use Disorders-Residential Treatment | |
2021-ABH-1135 | Drug Biological Policy | 10/12/21 | 11/27/21 | Approved | Drug Biological Policy | |
2021-ACLA-1148 | Unlisted Studies | 10/12/21 | 11/26/21 | Approved | Unlisted Studies | |
2021-ACLA-1147 | Brain PET Scan | 10/12/21 | 11/26/21 | Approved | Brain PET Scan | |
2021-HBL-1145 | Neuromuscular Stimulation in the Treatment of Muscle Atrophy | 10/12/21 | 11/26/21 | Approved | Neuromuscular Stimulation in the Treatment of Muscle Atrophy | |
2021-ACLA-893 | Abdomen CT Angiography | 10/12/21 | 11/26/21 | Approved | Abdomen CT Angiography | |
2021-ACLA-892 | Abdomen CT | 10/12/21 | 11/26/21 | Approved | Abdomen CT | |
2021-ACLA-891 | Abdomen MRI, MRCP | 10/12/21 | 11/26/21 | Approved | Abdomen MRI, MRCP | |
2021-ACLA-890 | Abdomen/Pelvis CT Combo | 10/12/21 | 11/26/21 | Approved | Abdomen/Pelvis CT Combo | |
2021-ACLA-889 | Abdomen MRA (Angiography) | 10/12/21 | 11/26/21 | Approved | Abdomen MRA (Angiography) | |
2021-ACLA-888 | Abdomen/Pelvis CT Combo | 10/12/21 | 11/26/21 | Approved | Abdomen/Pelvis CT Combo | |
2021-ACLA-887 | Abdominal Arteries CT Angiography | 10/12/21 | 11/26/21 | Approved | Abdominal Arteries CT Angiography | |
2021-ACLA-886 | Bone Marrow MRI | 10/12/21 | 11/26/21 | Approved | Bone Marrow MRI | |
2021-ACLA-885 | Brain (Head) CTA | 10/12/21 | 11/26/21 | Approved | Brain (Head) CTA | |
2021-ACLA-884 | Brain (Head) MRA/MRV | 10/12/21 | 11/26/21 | Approved | Brain (Head) MRA/MRV | |
2021-ACLA-883 | Brain (Head) CT | 10/12/21 | 11/26/21 | Approved | Brain (Head) CT | |
2021-ACLA-882 | Brain (Head) MRI, Brain (Head) MRI with IAC (Internal Auditory Canal) | 10/12/21 | 11/26/21 | Approved | Brain (Head) MRI, Brain (Head) MRI with IAC (Internal Auditory Canal) | |
2021-ACLA-881 | Cervical Spine CT | 10/12/21 | 11/26/21 | Approved | Cervical Spine CT | |
2021-ACLA-880 | Cervical Spine MRI | 10/12/21 | 11/26/21 | Approved | Cervical Spine MRI | |
2021-ACLA-879 | Brain (Head) MRS | 10/12/21 | 11/26/21 | Approved | Brain (Head) MRS | |
2021-ACLA-878 | Chest (Thorax) MRI | 10/12/21 | 11/26/21 | Approved | Chest (Thorax) MRI | |
2021-ACLA-877 | Chest MRA | 10/12/21 | 11/26/21 | Approved | Chest MRA | |
2021-ACLA-876 | Chest CTA | 10/12/21 | 11/26/21 | Approved | Chest CTA | |
2021-ACLA-875 | Chest (Thorax) CT | 10/12/21 | 11/26/21 | Approved | Chest (Thorax) CT | |
2021-ACLA-874 | CT Virtual Colonoscopy | 10/12/21 | 11/26/21 | Approved | CT Virtual Colonoscopy | |
2021-ACLA-873 | CT Bone Density Study | 10/12/21 | 11/26/21 | Approved | CT Bone Density Study | |
2021-ACLA-872 | CT Coronary Angiography (CCTA) | 10/12/21 | 11/26/21 | Approved | CT Coronary Angiography (CCTA) | |
2021-ACLA-871 | Sinus Face Orbit MRI | 10/12/21 | 11/26/21 | Approved | Sinus Face Orbit MRI | |
2021-ACLA-870 | Temporal Bone, Mastoid, Orbits, Sella, Internal Auditory Canal MRI | 10/12/21 | 11/26/21 | Approved | Temporal Bone, Mastoid, Orbits, Sella, Internal Auditory Canal MRI | |
2021-ACLA-869 | Sinus & Maxillofacial CT | 10/12/21 | 11/26/21 | Approved | Sinus & Maxillofacial CT | |
2021-ACLA-868 | Spinal Canal MRA | 10/12/21 | 11/26/21 | Approved | Spinal Canal MRA | |
2021-ACLA-867 | Temporomandibular Joint (TMJ) MRI | 10/12/21 | 11/26/21 | Approved | Temporomandibular Joint (TMJ) MRI | |
2021-ACLA-866 | Thoracic Spine CT | 10/12/21 | 11/26/21 | Approved | Thoracic Spine CT | |
2021-ACLA-865 | Upper Extremity CTA/CTV | 10/12/21 | 11/26/21 | Approved | Upper Extremity CTA/CTV | |
2021-ACLA-864 | Lower Extremity CTA/CTV | 10/12/21 | 11/26/21 | Approved | Lower Extremity CTA/CTV | |
2021-ACLA-863 | Thoracic Spine MRI | 10/12/21 | 11/26/21 | Approved | Thoracic Spine MRI | |
2021-ACLA-862 | Upper Extremity CTA/CTV | 10/12/21 | 11/26/21 | Approved | Upper Extremity CTA/CTV | |
2021-ACLA-861 | Breast MRI | 10/12/21 | 11/26/21 | Approved | Breast MRI | |
2021-ACLA-859 | Upper Extremity MRI | 10/12/21 | 11/26/21 | Approved | Upper Extremity MRI | |
2021-ACLA-858 | Upper Extremity MRA/MRV | 10/12/21 | 11/26/21 | Approved | Upper Extremity MRA/MRV | |
2021-ACLA-857 | CT Heart, CT Heart Congenital | 10/12/21 | 11/26/21 | Approved | CT Heart, CT Heart Congenital | |
2021-ACLA-856 | Functional Brain MRI | 10/12/21 | 11/26/21 | Approved | Functional Brain MRI | |
2021-ACLA-855 | Heart (cardiac) PET | 10/12/21 | 11/26/21 | Approved | Heart (cardiac) PET | |
2021-ACLA-854 | EBCT | 10/12/21 | 11/26/21 | Approved | EBCT | |
2021-ACLA-853 | Heart MRI | 10/12/21 | 11/26/21 | Approved | Heart MRI | |
2021-ACLA-852 | Heart (Cardiac) PET withy CT for Attenuation | 10/12/21 | 11/26/21 | Approved | Heart (Cardiac) PET withy CT for Attenuation | |
2021-ACLA-851 | Low Dose CT for Lung Cancer Screening | 10/12/21 | 11/26/21 | Approved | Low Dose CT for Lung Cancer Screening | |
2021-ACLA-850 | Lower Extremity CT | 10/12/21 | 11/26/21 | Approved | Lower Extremity CT | |
2021-ACLA-849 | Lower Extremity MRA/MRV | 10/12/21 | 11/26/21 | Approved | Lower Extremity MRA/MRV | |
2021-ACLA-848 | Lower Extremity MRI | 10/12/21 | 11/26/21 | Approved | Lower Extremity MRI | |
2021-ACLA-847 | Lumbar Spine MRI | 10/12/21 | 11/26/21 | Approved | Lumbar Spine MRI | |
2021-ACLA-846 | Lumbar Spine CT | 10/12/21 | 11/26/21 | Approved | Lumbar Spine CT | |
2021-ACLA-845 | MPI Myocardial Perfusion Imaging | 10/12/21 | 11/26/21 | Approved | MPI Myocardial Perfusion Imaging | |
2021-ACLA-844 | Low Field MRI | 10/12/21 | 11/26/21 | Approved | Low Field MRI | |
2021-ACLA-843 | Neck CT | 10/12/21 | 11/26/21 | Approved | Neck CT | |
2021-ACLA-842 | MUGA Multiple Gated Acquisition Scan | 10/12/21 | 11/26/21 | Approved | MUGA Multiple Gated Acquisition Scan | |
2021-ACLA-841 | Neck CTA | 10/12/21 | 11/26/21 | Approved | Neck CTA | |
2021-ACLA-840 | Neck MRA/MRV | 10/12/21 | 11/26/21 | Approved | Neck MRA/MRV | |
2021-ACLA-839 | Pelvis CT | 10/12/21 | 11/26/21 | Approved | Pelvis CT | |
2021-ACLA-838 | Pelvis CT Angiography | 10/12/21 | 11/26/21 | Approved | Pelvis CT Angiography | |
2021-ACLA-837 | Pelvis MRA | 10/12/21 | 11/26/21 | Approved | Pelvis MRA | |
2021-ACLA-836 | Pelvis MRI | 10/12/21 | 11/26/21 | Approved | Pelvis MRI | |
2021-ABH-1129 | Home Health Home Infusion | 10/11/21 | 11/25/21 | Approved | Home Health Home Infusion | |
2021-LDH-12 | MCO Manual > Part 4: Services > Medical Transportation > Ambulance (Proposed effective date = 12/27/2021) | 10/7/21 | 11/21/21 | Completed | MCO Manual > Part 4: Services > Medical Transportation > Ambulance (Proposed effective date = 12/27/2021) | |
2021-HBL-1092 | Cryoneurolysis for Treatment of Peripheral Nerve Pain | 10/1/21 | 11/15/21 | Approved | Cryoneurolysis for Treatment of Peripheral Nerve Pain | |
2021-HBL-1116 | Pre-Certification of Requested Services | 10/1/21 | 11/15/21 | Approved | Pre-Certification of Requested Services | |
2021-ABH-1131 | Revenue Code-HCPCS Code Links | 10/1/21 | 11/15/21 | Approved | Revenue Code-HCPCS Code Links | |
2021-HBL-1146 | Oral, Pharyn and Maxillo Surg Tx for Obstructive Sleep Apnea or Snoring | 10/1/21 | 11/15/21 | Approved | Oral, Pharyn and Maxillo Surg Tx for Obstructive Sleep Apnea or Snoring | |
2021-HBL-1144 | Vacuum Assisted Wound Therapy in the outpatient setting | 9/24/21 | 11/8/21 | Approved | Vacuum Assisted Wound Therapy in the outpatient setting | |
2021-HBL-1143 | Machie Learn der prob for rapid Kidney | 9/24/21 | 11/8/21 | Approved | Machie Learn der prob for rapid Kidney | |
2021-HBL-1142 | Perirectal Spacers for Use During Prostate Radiotherapy | 9/24/21 | 11/8/21 | Approved | Perirectal Spacers for Use During Prostate Radiotherapy | |
2021-ABH-1126 | Non-OB Ultrasound Redundant Policy | 9/24/21 | 11/8/21 | Approved | Non-OB Ultrasound Redundant Policy | |
2021-HBL-543 | Screening and Assessment for Autism Spectrum Disorders and Rett Syndrome | 9/22/21 | 11/6/21 | Approved | Screening and Assessment for Autism Spectrum Disorders and Rett Syndrome | |
2021-HBL-598 | Janus Kinase 2 CALR and MPL GENE Mutation Assays | 9/22/21 | 11/6/21 | Approved | Janus Kinase 2 CALR and MPL GENE Mutation Assays | |
2021-HBL-600 | Tonsillectomy for Children with or without Adenoidectomy | 9/22/21 | 11/6/21 | Approved | Tonsillectomy for Children with or without Adenoidectomy | |
2021-HBL-1140 | Prostate Biopsy using MRI Fusion Techniques | 9/22/21 | 11/6/21 | Approved | Prostate Biopsy using MRI Fusion Techniques | |
2021-HBL-1141 | Paired DNA and Messenger RNA (mRNA) Genetic Test to Detect, Diag Mng Cancer | 9/22/21 | 11/6/21 | Approved | Paired DNA and Messenger RNA (mRNA) Genetic Test to Detect, Diag Mng Cancer | |
2021-LDH-11 | Part 4: Services > Professional Services > Skin Substitutes | 9/22/21 | 11/6/21 | Completed | MCO Manual: Skin Substitutes | |
2021-LDH-10 | Part 4: Services > Medical Transportation (NEMT) | 9/14/21 | 10/29/21 | Completed | Medical Transportation: NEMT | |
2021-UHC-1123 | Extracorporeal Shock Wave Therapy (ESWT) for Musculoskeletal Conditions and Soft Tissue Wounds | 8/17/21 | 9/30/21 | Approved | Extracorporeal Shock Wave Therapy (ESWT) for Musculoskeletal Conditions and Soft Tissue Wounds | |
2021-UHC-1122 | Percutaneous Vertebroplasty and Kyphoplasty | 8/17/21 | 9/30/21 | Approved | Percutaneous Vertebroplasty and Kyphoplasty | |
2021-UHC-1121 | Intrauterine Fetal Surgery | 8/17/21 | 9/30/21 | Approved | Intrauterine Fetal Surgery | |
2021-UHC-1120 | Percutaneous Patent Foramen Ovale (PFO) Closure | 8/17/21 | 9/30/21 | Approved | Percutaneous Patent Foramen Ovale (PFO) Closure | |
2021-UHC-1119 | Bronchial Thermoplasty | 8/17/21 | 9/30/21 | Approved | Bronchial Thermoplasty | |
2021-LHCC-1118 | Preventive Health and Clinical Practice Guidelines | 8/17/21 | 9/30/21 | Completed | Preventive Health and Clinical Practice Guidelines | |
2021-UHC-378 | Surgery of the Shoulder | 8/17/21 | 9/30/21 | Approved | Surgery of the Shoulder | |
2021-LHCC-1117 | Contract Effective Date | 8/13/21 | 9/26/21 | Completed | Contract Effective Date | |
2021-LDH-9 | Part 4: Services > Professional Services > Early and Periodic Screening, Diagnostic, and Treatment Preventive Services Program | 8/11/21 | 9/25/21 | Completed | EPSDT Preventive Services Program | |
2021-LDH-8 | Part 4: Services > Professional Services > Physician Administered Medication | 8/6/21 | 9/20/21 | Completed | Physician Administered Medication | |
2021-LDH-7 | Part 4: Services > Professional Services > Genetic Testing | 7/27/2021 | 9/10/2021 | Completed | MCO Manual – Genetic Counseling | |
2021-ACLA-1106 | Avesis Eye Authorizations | 7/29/21 | 9/12/21 | Approved | Avesis Eye Authorizations | |
2021-ACLA-1104 | Chest (Thorax) CT | 7/26/21 | 9/9/21 | Approved | Chest (Thorax) CT | |
2021-ACLA-1105 | Low Dose CT for Lung Cancer Screening | 7/26/21 | 9/9/21 | Approved | Low Dose CT for Lung Cancer Screening | |
2021-HBL-1008 | PDHC & PCS | 7/22/21 | 9/5/21 | Approved | PDHC & PCS | |
2021-UHC-823 | Provider Manual | 7/20/21 | 9/2/21 | Approved | Provider Manual | |
2021-LHCC-993 | Administrative Denials | 7/2/21 | 8/16/21 | Approved | Administrative Denials | |
2021-HBL-1102 | Allogeneic, Xenographic, Synthetic and Composite Products for Wound Healing and Soft TissueGrafting | 7/1/21 | 8/15/21 | Approved | Allogeneic, Xenographic, Synthetic and Composite Products for Wound Healing and Soft TissueGrafting | |
2021-HBL-1101 | Cardiac Contractility Modulation Therapy | 7/1/21 | 8/15/21 | Approved | Cardiac Contractility Modulation Therapy | |
2021-HBL-1100 | Uterine Transplantation | 7/1/21 | 8/15/21 | Approved | Uterine Transplantation | |
2021-HBL-1099 | Focal Laser Ablation for the treatment of Prostate Cancer | 7/1/21 | 8/15/21 | Approved | Focal Laser Ablation for the treatment of Prostate Cancer | |
2021-HBL-1098 | Mechanical Circulatory Assist Device | 7/1/21 | 8/15/21 | Approved | Mechanical Circulatory Assist Device | |
2021-HBL-1097 | Implantable Peripheral Nerve Stimulation Devices | 7/1/21 | 8/15/21 | Approved | Implantable Peripheral Nerve Stimulation Devices | |
2021-HBL-1096 | Minimally Invasive treatment of the Posterior Nasal Nerve to treat Rhinitis | 7/1/21 | 8/15/21 | Approved | Minimally Invasive treatment of the Posterior Nasal Nerve to treat Rhinitis | |
2021-HBL-1095 | Implanted Artificial Iris Device | 7/1/21 | 8/15/21 | Approved | Implanted Artificial Iris Device | |
2021-HBL-1094 | Electrophysiolgy – Guided Non-invasive Stereotactic Cardiac Radioblation | 7/1/21 | 8/15/21 | Approved | Electrophysiolgy – Guided Non-invasive Stereotactic Cardiac Radioblation | |
2021-HBL-1093 | Microsurgical Procedures for the treatment of Lymphedema | 7/1/21 | 8/15/21 | Approved | Microsurgical Procedures for the treatment of Lymphedema | |
2021-HBL-1092 | Cryoneurolysis for treatment of Peripheral Nerve Pain | 7/1/21 | 8/15/21 | Approved | Cryoneurolysis for treatment of Peripheral Nerve Pain | |
2021-HBL-804 | Non-Hematopoietic Adult Stem Cell Therapy | 7/1/21 | 8/15/21 | Approved | Non-Hematopoietic Adult Stem Cell Therapy | |
2021-HBL-1091 | Transcatheter Heart Valve Procedures | 6/28/21 | 8/12/21 | Approved | Transcatheter Heart Valve Procedures | |
2021-HBL-1090 | Internal Rib Fixation | 6/28/21 | 8/12/21 | Approved | Internal Rib Fixation | |
2021-HBL-1089 | Implantation of Occippiral, Supraorbital or Trigeminal Nerve Stimulation Device | 6/28/21 | 8/12/21 | Approved | Implantation of Occippiral, Supraorbital or Trigeminal Nerve Stimulation Device | |
2021-HBL-1088 | Vertebral Body Stapling | 6/28/21 | 8/12/21 | Approved | Vertebral Body Stapling | |
2021-HBL-1087 | Uterine Fibroid Ablation | 6/28/21 | 8/12/21 | Approved | Uterine Fibroid Ablation | |
2021-HBL-1086 | Vein Embolization | 6/28/21 | 8/12/21 | Approved | Vein Embolization | |
2021-HBL-1085 | Transendoscopic Therapy | 6/28/21 | 8/12/21 | Approved | Transendoscopic Therapy | |
2021-HBL-1084 | Extracorporeal Shock Wave | 6/28/21 | 8/12/21 | Approved | Extracorporeal Shock Wave | |
2021-HBL-803 | Percutaneoud Vertebral Disc and Vertebral Endplate Procedures | 6/28/21 | 8/12/21 | Approved | Percutaneoud Vertebral Disc and Vertebral Endplate Procedures | |
2021-HBL-591 | Wireless Cardiac Resynchronization Therapy | 6/28/21 | 8/12/21 | Approved | Wireless Cardiac Resynchronization Therapy | |
2021-HBL-1083 | Treatment of Varicose Veins | 6/25/21 | 8/9/21 | Approved | Treatment of Varicose Veins | |
2021-HBL-1082 | Patent Foramen Ovale and Left Atrial Appendage Closure Devices for Stroke Prevention | 6/25/21 | 8/9/21 | Approved | Patent Foramen Ovale and Left Atrial Appendage Closure Devices for Stroke Prevention | |
2021-HBL-1081 | Non-Invasive HF and Arrhythmia and Monitoring System | 6/25/21 | 8/9/21 | Approved | Non-Invasive HF and Arrhythmia and Monitoring System | |
2021-HBL-1080 | Ingestion Event Monitors | 6/25/21 | 8/9/21 | Approved | Ingestion Event Monitors | |
2021-HBL-1079 | Adipose-derived Regenerative Cell Therapy and Soft Tissue Augmentation | 6/25/21 | 8/9/21 | Approved | Adipose-derived Regenerative Cell Therapy and Soft Tissue Augmentation | |
2021-HBL-1078 | Electronic Home Visual Field Monitoring | 6/25/21 | 8/9/21 | Approved | Electronic Home Visual Field Monitoring | |
2021-HBL-1077 | Insulin Potentiation Therapy | 6/25/21 | 8/9/21 | Approved | Insulin Potentiation Therapy | |
2021-HBL-1076 | Chelation Therapy | 6/25/21 | 8/9/21 | Approved | Chelation Therapy | |
2021-HBL-1075 | Gene Therapy for Ocular Conditions Medical Policy | 6/25/21 | 8/9/21 | Approved | Gene Therapy for Ocular Conditions Medical Policy | |
2021-HBL-1074 | Optical Detection for Screen and Ident of Cervical Cancer | 6/25/21 | 8/9/21 | Approved | Optical Detection for Screen and Ident of Cervical Cancer | |
2021-HBL-1073 | Tech for the evaluation of Skin Lesions | 6/25/21 | 8/9/21 | Approved | Tech for the evaluation of Skin Lesions | |
2021-HBL-1072 | Pooled Antibiotic Sensitivity Testing | 6/25/21 | 8/9/21 | Approved | Pooled Antibiotic Sensitivity Testing | |
2021-HBL-1071 | Cell-free DNA Test to Aid in the Monitoring of Kidney Trans for Rejection | 6/25/21 | 8/9/21 | Approved | Cell-free DNA Test to Aid in the Monitoring of Kidney Trans for Rejection | |
2021-HBL-1070 | Serologic Testing for Biomarkers of IBS | 6/25/21 | 8/9/21 | Approved | Serologic Testing for Biomarkers of IBS | |
2021-HBL-1069 | Protein Biomarkers for the Screening Detection and Management of Prostate Cancer | 6/25/21 | 8/9/21 | Approved | Protein Biomarkers for the Screening Detection and Management of Prostate Cancer | |
2021-HBL-1068 | Selected Blood Serum and Cellular Allergy and Toxicity Tests Policy | 6/25/21 | 8/9/21 | Approved | Selected Blood Serum and Cellular Allergy and Toxicity Tests Policy | |
2021-HBL-1067 | Analysis of Proteomic Patterns | 6/25/21 | 8/9/21 | Approved | Analysis of Proteomic Patterns | |
2021-HBL-1066 | Gene Expression Profiling for Bladder Cancer Policy | 6/25/21 | 8/9/21 | Approved | Gene Expression Profiling for Bladder Cancer Policy | |
2021-HBL-1065 | Gene Expression Profiling for Risk Strat of IBD severity | 6/25/21 | 8/9/21 | Approved | Gene Expression Profiling for Risk Strat of IBD severity | |
2021-HBL-802 | Growth Factors, Silver-based Products and Autologous Tissues for Wound Treatment, Soft Tissue Grafting, and Regenerative Therapy | 6/25/21 | 8/9/21 | Approved | Growth Factors, Silver-based Products and Autologous Tissues for Wound Treatment, Soft Tissue Grafting, and Regenerative Therapy | |
2021-HBL-796 | Surface Electromyography Devices for Seizure Monitoring | 6/25/21 | 8/9/21 | Approved | Surface Electromyography Devices for Seizure Monitoring | |
2021-HBL-594 | Genotype Testing for Genetic Polymorphisms to determine Drug-Metabolizer status | 6/25/21 | 8/9/21 | Approved | Genotype Testing for Genetic Polymorphisms to determine Drug-Metabolizer status | |
2021-ACLA-997 | Optometry Prior Authorization requirement revisions | 6/24/21 | 8/8/21 | Approved | Optometry Prior Authorization requirement revisions fee schedule Optometry Prior Authorization requirement revisions memorandum | |
2021-ACLA-996 | Ophthalmology Prior Authorization requirement revisions | 6/24/21 | 8/8/21 | Approved | Ophthalmology Prior Authorization requirement revisions fee schedule Ophthalmology Prior Authorization requirement revisions memorandum | |
2021-ACLA-995 | Ocularist Prior Authorization requirement revisions | 6/24/21 | 8/8/21 | Approved | Ocularist Prior Authorization requirement revisions fee schedule Ocularist Prior Authorization requirement revisions memorandum | |
2021-UHC-1064 | Utilization Management of Behavioral Health Benefits Addendum | 6/23/21 | 8/7/21 | Approved | Utilization Management of Behavioral Health Benefits Addendum | |
2021-UHC-1063 | Temporomandibular Joint Disorder | 6/23/21 | 8/7/21 | Approved | Temporomandibular Joint Disorder | |
2021-HBL-1062 | Metagenomic Sequencing for Infectious Disease in the outpatient setting | 6/23/21 | 8/7/21 | Approved | Metagenomic Sequencing for Infectious Disease in the outpatient setting | |
2021-HBL-1061 | Venous Angiop w or w/out Stent Placement or Venous Stent Alone | 6/23/21 | 8/7/21 | Approved | Venous Angiop w or w/out Stent Placement or Venous Stent Alone | |
2021-HBL-1060 | Level of Care - Specialty Pharmaceitcals | 6/23/21 | 8/7/21 | Approved | Level of Care - Specialty Pharmaceitcals | |
2021-HBL-1059 | HIFU for Oncologic Indications | 6/23/21 | 8/7/21 | Approved | HIFU for Oncologic Indications | |
2021-HBL-1058 | Whole Genome Sequ. Whole Exome Sequ. Gene Panels and Molecular Prof | 6/23/21 | 8/7/21 | Approved | Whole Genome Sequ. Whole Exome Sequ. Gene Panels and Molecular Prof | |
2021-HBL-1057 | Bronchial Gene Exp Class for the Diagnostic Eval of Lung Cancer | 6/23/21 | 8/7/21 | Approved | Bronchial Gene Exp Class for the Diagnostic Eval of Lung Cancer | |
2021-HBL-1056 | Elec Posit Devices for the treatment of Obstructive Sleep Apnea | 6/23/21 | 8/7/21 | Approved | Elec Posit Devices for the treatment of Obstructive Sleep Apnea | |
2021-HBL-1055 | Low Intensity Therapeutic Ultrasound for the treatment of pain | 6/23/21 | 8/7/21 | Approved | Low Intensity Therapeutic Ultrasound for the treatment of pain | |
2021-HBL-1054 | Cooling Devices and Combined Cooling-Heating Devices | 6/23/21 | 8/7/21 | Approved | Cooling Devices and Combined Cooling-Heating Devices | |
2021-HBL-1053 | Elect Stim as a Trtmnt for Pain and Other Cond-Surf and Percut Devices | 6/23/21 | 8/7/21 | Approved | Elect Stim as a Trtmnt for Pain and Other Cond-Surf and Percut Devices | |
2021-HBL-1052 | Panniculectomy and Abdominoplasty | 6/23/21 | 8/7/21 | Approved | Panniculectomy and Abdominoplasty | |
2021-HBL-1051 | Cardioverter Defibrillators | 6/23/21 | 8/7/21 | Approved | Cardioverter Defibrillators | |
2021-HBL-1050 | Minimally Invasive Ablative Procedures for Elipesy | 6/23/21 | 8/7/21 | Approved | Minimally Invasive Ablative Procedures for Elipesy | |
2021-HBL-1049 | Reduction Mammoplasty | 6/23/21 | 8/7/21 | Approved | Reduction Mammoplasty | |
2021-HBL-1048 | Intracardiac Electrophysiological Studies | 6/23/21 | 8/7/21 | Approved | Intracardiac Electrophysiological Studies | |
2021-HBL-1047 | Gender Reassignment Surgery | 6/23/21 | 8/7/21 | Approved | Gender Reassignment Surgery | |
2021-HBL-1046 | Stereotactic Radiofrequency Pallidotomy | 6/23/21 | 8/7/21 | Approved | Stereotactic Radiofrequency Pallidotomy | |
2021-HBL-1045 | Surgical and Minimally Invasive Treatments for Benign Prostatic Hyperplasia | 6/23/21 | 8/7/21 | Approved | Surgical and Minimally Invasive Treatments for Benign Prostatic Hyperplasia | |
2021-HBL-811 | HBL-Locoregional and Surgical Techniques for Treating Primary and Metastatic Liver Malignancies | 6/23/21 | 8/7/21 | Approved | HBL-Locoregional and Surgical Techniques for Treating Primary and Metastatic Liver Malignancies | |
2021-HBL-800 | Prothrombin Genetic Testing | 6/23/21 | 8/7/21 | Approved | Prothrombin Genetic Testing | |
2021-HBL-798 | Gene Expression Profiling of Melanomas | 6/23/21 | 8/7/21 | Approved | Gene Expression Profiling of Melanomas | |
2021-HBL-589 | Non-Covered and Cost Effective Alternative Services | 6/23/21 | 8/7/21 | Approved | Non-Covered and Cost Effective Alternative Services | |
2021-HBL-599 | Temporomandibular Disorders | 6/17/21 | 7/31/21 | Approved | Temporomandibular Disorders | |
2021-HBL-807 | Male Circumcision | 6/17/21 | 7/31/21 | Approved | Male Circumcision | |
2021-HBL-983 | Professional Anesthesia | 6/17/21 | 7/31/21 | Approved | Professional Anesthesia | |
2021-HBL-1041 | Cranial Remodeling Bands and Helmets | 6/17/21 | 7/31/21 | Approved | Cranial Remodeling Bands and Helmets | |
2021-HBL-1042 | Ablative Techniques as a treatment for Barrett’s Esophagus | 6/17/21 | 7/31/21 | Approved | Ablative Techniques as a treatment for Barrett’s Esophagus | |
2021-HBL-1043 | Alcohol Septal Ablation for treatment of Hypertrophic Cardiomyopathy | 6/17/21 | 7/31/21 | Approved | Alcohol Septal Ablation for treatment of Hypertrophic Cardiomyopathy | |
2021-HBL-1044 | Intraoperative Neurophysiological Monitoring | 6/17/21 | 7/31/21 | Approved | Intraoperative Neurophysiological Monitoring | |
2021-LDH-6 | Part 7: Provider Services > Enrollee Reassignment Policy | 6/10/21 | 7/25/2021 | Pending | Part 7: Provider Services > Enrollee Reassignment Policy | |
2021-LHCC-912 | Medical Management | 6/10/21 | 7/25/21 | Approved | Medical Management - Attachment 1, Attachment 2, Attachment 3, Attachment 4, Attachment 5, Attachment 6, Attachment 7, Attachment 8, Attachment 9, Attachment 10 | |
2021-HBL-1040 | Genetic Testing for PTEN Hematoma Tumor Syndrome | 6/14/21 | 7/28/21 | Approved | Genetic Testing for PTEN Hematoma Tumor Syndrome | |
2021-HBL-1039 | BCR-ABLK Mutation Analysis | 6/14/21 | 7/28/21 | Approved | BCR-ABLK Mutation Analysis | |
2021-HBL-1038 | Enhanced External Counter pulsation in the outpatient setting | 6/14/21 | 7/28/21 | Approved | Enhanced External Counter pulsation in the outpatient setting | |
2021-HBL-1037 | Posterior Segment Optical Coherence Tomography | 6/14/21 | 7/28/21 | Approved | Posterior Segment Optical Coherence Tomography | |
2021-HBL-1036 | Home Health Utilization Management | 6/14/21 | 7/28/21 | Approved | Home Health Utilization Management | |
2021-HBL-1035 | Diaphragmatic/Phrenic Nerve stim and Diaph Pacing system | 6/14/21 | 7/28/21 | Approved | Diaphragmatic/Phrenic Nerve stim and Diaph Pacing system | |
2021-HBL-1034 | Anesthesia Services for Interventional Pain Management | 6/14/21 | 7/28/21 | Approved | Anesthesia Services for Interventional Pain Management | |
2021-HBL-1033 | Therapeutic Apheresis | 6/14/21 | 7/28/21 | Approved | Therapeutic Apheresis | |
2021-HBL-1032 | Transcath ablation of arrhyth foci in the pulm veins | 6/14/21 | 7/28/21 | Approved | Transcath ablation of arrhyth foci in the pulm veins | |
2021-ACLA-1029 | Endovascular treatment for intermittent claudication | 6/14/21 | 7/28/21 | Approved | Endovascular treatment for intermittent claudication | |
2021-HBL-1028 | Molecular (GIPP) Testing for Infectious Diarrhea in the outpatient setting | 6/14/21 | 7/28/21 | Approved | Molecular (GIPP) Testing for Infectious Diarrhea in the outpatient setting | |
2021-HBL-1027 | Red blood cell folic acid testing | 6/14/21 | 7/28/21 | Approved | Red blood cell folic acid testing | |
2021-HBL-1026 | Gene Expression Profiling for managing breast cancer treatment | 6/14/21 | 7/28/21 | Approved | Gene Expression Profiling for managing breast cancer treatment | |
2021-HBL-1025 | Detect and Quant of tumor DNA Usage next gen sequence in lymph cancers | 6/14/21 | 7/28/21 | Approved | Detect and Quant of tumor DNA Usage next gen sequence in lymph cancers | |
2021-HBL-1024 | Gene Mutat Test for solid tumor cancer susceptibility and management | 6/14/21 | 7/28/21 | Approved | Gene Mutat Test for solid tumor cancer susceptibility and management | |
2021-HBL-1023 | Genetic Testing for Inherited Disease | 6/14/21 | 7/28/21 | Approved | Genetic Testing for Inherited Disease | |
2021-HBL-1022 | Genotype Test for Individual Genetic Polymorph to determine Drug-metab status | 6/14/21 | 7/28/21 | Approved | Genotype Test for Individual Genetic Polymorph to determine Drug-metab status | |
2021-HBL-1015 | Mobile Devise-Based Health Management applications | 6/14/21 | 7/28/21 | Approved | Mobile Devise-Based Health Management applications | |
2021-LHCC-994 | Ambularoty Insulin Pump | 6/14/21 | 7/28/21 | Approved | Ambularoty Insulin Pump | |
2021-HBL-810 | Bone Mineral Density Testing Measurement | 6/14/21 | 7/28/21 | Approved | Bone Mineral Density Testing Measurement | |
2021-HBL-809 | Inpatient Inter-facility Transfers | 6/14/21 | 7/28/21 | Approved | Inpatient Inter-facility Transfers | |
2021-HBL-805 | Nininvasive Home Ventilator Therapy for Respiratory Failure | 6/14/21 | 7/28/21 | Approved | Nininvasive Home Ventilator Therapy for Respiratory Failure | |
2021-HBL-801 | Single Photon Emission CTS for Non-cardiovascular Indications | 6/14/21 | 7/28/21 | Approved | Single Photon Emission CTS for Non-cardiovascular Indications | |
2021-HBL-597 | Electric Tumor Treatment Field | 6/14/21 | 7/28/21 | Approved | Electric Tumor Treatment Field | |
2021-HBL-590 | Gene Expression Profiling for Coronary Artery Disease | 6/14/21 | 7/28/21 | Approved | Gene Expression Profiling for Coronary Artery Disease | |
2021-HBL-999 | UM AROW 1327 PA Requirements | 6/8/21 | 7/23/21 | Approved | UM AROW 1327 PA Requirements | |
2021-HBL-1004 | UM AROW 1837 PA Requirements | 6/8/21 | 7/23/21 | Approved | UM AROW 1837 PA Requirements | |
2021-HBL-1005 | UM AROW 1576 PA Requirements | 6/8/21 | 7/23/21 | Approved | UM AROW 1576 PA Requirements | |
2021-HBL-1014 | Imaging of the Chest (AIM) | 6/7/21 | 7/22/21 | Approved | Imaging of the Chest (AIM) | |
2021-HBL-1013 | Imaging of the Head and Neck (AIM) | 6/7/21 | 7/22/21 | Approved | Imaging of the Head and Neck (AIM) | |
2021-HBL-1012 | Oncology Imaging (AIM) | 6/7/21 | 7/22/21 | Approved | Oncology Imaging (AIM) | |
2021-HBL-1011 | Radiation Oncology (AIM) | 6/7/21 | 7/22/21 | Approved | Radiation Oncology (AIM) | |
2021-HBL-1010 | Imaging of the Brain (AIM) | 6/7/21 | 7/22/21 | Approved | Imaging of the Brain (AIM) | |
2021-HBL-1009 | Advanced Imaging of the Heart (AIM) | 6/7/21 | 7/22/21 | Approved | Advanced Imaging of the Heart (AIM) | |
2021-HBL-985 | Small Joint Surgery Criteria (AIM) | 6/7/21 | 7/22/21 | Approved | Small Joint Surgery Criteria (AIM) | |
2021-UHC-961 | Elective Inpatient Services | 6/7/21 | 7/22/21 | Approved | Elective Inpatient Services | |
2021-HBL-256 | Member Complaints and Grievances | 6/7/21 | 7/22/21 | Approved | Member Complaints and Grievances | |
2021-LHCC-338 | Perinatal Substance Use Disorder Care Management Program | 5/27/21 | 7/11/21 | Approved | Perinatal Substance Use Disorder Care Management Program | |
2021-LHCC-911 | Network Adequacy | 5/27/21 | 7/11/21 | Approved | Network Adequacy | |
2021-HBL-951 | Durable Medical Equipment | 5/27/21 | 7/11/21 | Approved | Durable Medical Equipment | |
2021-ABH-953 | Multi-Systemic Therapy (MST) | 5/27/21 | 7/11/21 | Approved | Multi-Systemic Therapy (MST) | |
2021-ABH-954 | Community Psychiatric Support and Treatment and Psychosocial Rehabilitation | 5/27/21 | 7/11/21 | Approved | Community Psychiatric Support and Treatment and Psychosocial Rehabilitation | |
2021-ABH-955 | Cris Intervention Services | 5/27/21 | 7/11/21 | Approved | Cris Intervention Services | |
2021-ABH-956 | Concurrent Review-Observation Care | 5/27/21 | 7/11/21 | Approved | Concurrent Review-Observation Care | |
2021-ABH-957 | Assertive Community Treatment Services | 5/27/21 | 7/11/21 | Approved | Assertive Community Treatment Services | |
2021-ACLA-984 | Behavioral Health Provider Quality Monitoring Plan | 5/27/21 | 7/11/21 | Approved | Behavioral Health Provider Quality Monitoring Plan | |
2021-ACLA-989 | Ambulance Services | 5/27/21 | 7/11/21 | Approved | Ambulance Services | |
2021-LDH-5 | Part 4: Services > Professional Services > Obstetrics | 5/20/21 | 7/4/21 | Pending | MCO Manual: Obstetrics -- Tobacco Cessation | |
2021-HBL-986 | Diagnostic Coronary Angiography | 5/20/21 | 7/3/21 | Approved | Diagnostic Coronary Angiography | |
2021-HBL-998 | Laser Trabeculoplasty and Laser Peripheral Iridotomy | 5/20/21 | 7/3/21 | Approved | Laser Trabeculoplasty and Laser Peripheral Iridotomy | |
2021-LHCC-990 | Medical Necessity Review |
5/20/21 | 7/3/21 | Completed | Medical Necessity Review |
|
2021-LHCC-991 | Concurrent Review | 5/20/21 | 7/3/21 | Completed | Concurrent Review | |
2021-LHCC-992 | Post Discharge Member Outreach Calls | 5/20/21 | 7/3/21 | Completed | Post Discharge Member Outreach Calls | |
2021-LHCC-140 | Timeliness of UM Decisions | 5/13/21 | 6/27/21 | Approved | Timeliness of UM Decisions Attachment 1 Attachment 2 | |
2021-LHCC-982 | Outpatient Applied Behavioral Analysis Medical Necessity | 5/13/21 | 6/27/21 | Approved | Outpatient Applied Behavioral Analysis Medical Necessity | |
2021-HBL-952 | Multiple and Bilateral Policy | 5/13/21 | 6/27/21 | Approved | Multiple and Bilateral Policy | |
2021-HBL-947 | Modifier 90 Reimbursement Policy | 5/13/21 | 6/27/21 | Approved | Modifier 90 Reimbursement Policy | |
2021-LHCC-915 | PASRR Level II Evaluations Work Plan | 5/13/21 | 6/27/21 | Approved | PASRR Level II Evaluations Work Plan | |
2021-LHCC-913 | PASRR Level II Evaluations | 5/13/21 | 6/27/21 | Approved | PASRR Level II Evaluations | |
2021-LHCC-606 | Grievance Process | 5/13/21 | 6/27/21 | Approved | Grievance Process | |
2021-LHCC-504 | Quality PIPs | 5/13/21 | 6/27/21 | Approved | Quality PIPs | |
2021-LHCC-501 | Access to Non-Emergency Transportation | 5/13/21 | 6/27/21 | Approved | Access to Non-Emergency Transportation | |
2021-LHCC-966 | Cultural and Linguistic Policy | 4/26/21 | 6/9/21 | Completed | Cultural and Linguistic Policy | |
2021-LHCC-965 | Member Provider Call Audit and Quality Criteria and Protocol | 4/26/21 | 6/9/21 | Completed | Member Provider Call Audit and Quality Criteria and Protocol | |
2021-LHCC-964 | Predictive Modeling Methodology | 4/26/21 | 6/9/21 | Approved | Predictive Modeling Methodology | |
2021-LHCC-919 | Website Guidelines | 4/26/21 | 6/9/21 | Completed | Website Guidelines | |
2021-LHCC-814 | Crisis Intervention Policy | 4/26/21 | 6/9/21 | Approved | Crisis Intervention Policy | |
2021-LHCC-605 | Provider Visit Schedule PP | 4/26/21 | 6/9/21 | Completed | Provider Visit Schedule PP | |
2021-LHCC-526 | TruCare Standards for Documentation policy | 4/26/21 | 6/9/21 | Approved | TruCare Standards for Documentation policy | |
2021-LHCC-499 | Retrospective Review For Services Requiring Authorizations | 4/26/21 | 6/9/21 | Approved | Retrospective Review For Services Requiring Authorizations | |
2021-LHCC-430 | Covered Benefits and Services | 4/26/21 | 6/9/21 | Approved | Covered Benefits and Services | |
2021-LHCC-934 | Behavioral Health Provider Quality Program | 4/20/21 | 6/3/21 | Approved | Behavioral Health Provider Quality Program | |
2021-UHC-960 | Criteria for Medical Necessity & Prior Authorization – PDN/EHH | 4/14/21 | 5/30/21 | Approved | Criteria for Medical Necessity & Prior Authorization – PDN/EHH | |
2021-UHC-959 | Criteria for Medical Necessity & Prior Authorization – EPSDT – PCS | 4/14/21 | 5/30/21 | Approved | Criteria for Medical Necessity & Prior Authorization – EPSDT – PCS | |
2021-UHC-958 | Criteria for Medical Necessity & Prior Authorization – PDHC | 4/14/21 | 5/30/21 | Approved | Criteria for Medical Necessity & Prior Authorization – PDHC | |
2021-HBL-946 | Member Appeals Core Policy | 4/14/21 | 5/30/21 | Approved | Member Appeals Core Policy | |
2021-LHCC-931 | Appeals Process | 4/14/21 | 5/30/21 | Approved | Appeals Process | |
2021-ABH-834 | EPSDT reimbursement | 4/14/21 | 5/30/21 | Approved | EPSDT reimbursement | |
2021-UHC-949 | Chemotherapy – Observation or Inpatient Hospitalization | 4/1/21 | 5/16/21 | Approved | Chemotherapy – Observation or Inpatient Hospitalization | |
2021-UHC-948 | Catheter Ablation for Atrial Fibrilation | 4/1/21 | 5/16/21 | Approved | Catheter Ablation for Atrial Fibrilation | |
2021-ABH-835 | Vaccines for Children | 3/31/21 | 5/15/21 | Approved | Vaccines for Children | |
2021-LHCC-927 | Medical Record Review | 3/18/21 | 5/2/21 | Approved | Medical Record Review | |
2021-LHCC-926 | Provider Appointment Accessibility Standards | 3/18/21 | 5/2/21 | Approved | Provider Appointment Accessibility Standards | |
2021-LHCC-925 | Provider Complaints | 3/18/21 | 5/2/21 | Approved | Provider Complaints | |
2021-LHCC-916 | CM Assessment Process | 3/18/21 | 5/2/21 | Approved | CM Assessment Process | |
2021-LHCC-830 | Coordination of Benefits (COB/TPL) Act 421 | 3/18/21 | 5/2/21 | Approved | Coordination of Benefits (COB/TPL) Act 421 | |
2021-LDH-4 |
|
3/17/21 | 5/1/21 | Pending | MCO Manual – Program Integrity | |
2021-LDH-3 | LDH MCO Manual Part 4: Services > Professional Services > Obstetrics | 3/17/21 | 5/1/21 | Pending | MCO Manual – Obstetrics | |
2021-ABH-937 | Portable X-ray Policy | 3/17/21 | 4/30/21 | Approved | Portable X-ray Policy | |
2021-LHCC-831 | Act 421 Children’s Medicaid Option Policy | 3/16/21 | 4/29/21 | Approved | Act 421 Children’s Medicaid Option Policy | |
2021-UHC-945 | Act 421 LaHipp Notice | 3/16/21 | 4/29/21 | Approved | Act 421 LaHipp Notice | |
2021-ABH-822 | ABH Provider Manual | 3/10/21 | 4/23/21 | Approved | ABH Provider Manual | |
2021-ACLA-944 | Assertive Community Treatment | 3/10/21 | 4/23/21 | Approved | Assertive Community Treatment | |
2021-ABH-942 | Urine Drug Testing Policy | 3/10/21 | 4/23/21 | Approved | Urine Drug Testing Policy | |
2021-ABH-939 | Non-Invasive Prenatal Testing Policy | 3/10/21 | 4/23/21 | Approved | Non-Invasive Prenatal Testing Policy | |
2021-ABH-935 | Obestrical Ultrasound Policy | 3/10/21 | 4/23/21 | Approved | Obestrical Ultrasound Policy | |
2021-ACLA-833 | Act 421 Update | 3/10/21 | 4/23/21 | Approved | Act 421 Update | |
2021-ACLA-893 | Abdomen CT Angiography CG | 3/4/21 | 4/17/21 | Approved | Abdomen CT Angiography CG | |
2021-ACLA-892 | Abdomen CT CG | 3/4/21 | 4/17/21 | Approved | Abdomen CT CG | |
2021-ACLA-891 | Abdomen MRI, MRCP CG | 3/4/21 | 4/17/21 | Approved | Abdomen MRI, MRCP CG | |
2021-ACLA-890 | Abdomen/Pelvis CT Combo CG | 3/4/21 | 4/17/21 | Approved | Abdomen/Pelvis CT Combo CG | |
2021-ACLA-889 | Abdomen MRA (Angiography) CG | 3/4/21 | 4/17/21 | Approved | Abdomen MRA (Angiography) CG | |
2021-ACLA-888 | Abdomen/Pelvis CTA Combo CG | 3/4/21 | 4/17/21 | Approved | Abdomen/Pelvis CTA Combo CG | |
2021-ACLA-887 | Abdominal Arteries CT Angiography CG | 3/4/21 | 4/17/21 | Approved | Abdominal Arteries CT Angiography CG | |
2021-ACLA-886 | Bone Marrow MRI CG | 3/4/21 | 4/17/21 | Approved | Bone Marrow MRI CG | |
2021-ACLA-885 | Brain (Head) CTA CG | 3/4/21 | 4/17/21 | Approved | Brain (Head) CTA CG | |
2021-ACLA-884 | Brain (Head) MRA/MRV CG | 3/4/21 | 4/17/21 | Approved | Brain (Head) MRA/MRV CG | |
2021-ACLA-883 | Brain (Head) CT CG | 3/4/21 | 4/17/21 | Approved | Brain (Head) CT CG | |
2021-ACLA-882 | Brain (Head) MRI, Brain (Head) MRI with IAC (Internal Auditory Canal) CG | 3/4/21 | 4/17/21 | Approved | Brain (Head) MRI, Brain (Head) MRI with IAC (Internal Auditory Canal) CG | |
2021-ACLA-881 | Cervical Spine CT CG | 3/3/21 | 4/16/21 | Approved | Cervical Spine CT CG | |
2021-ACLA-880 | Cervical Spine MRI CG | 3/3/21 | 4/16/21 | Approved | Cervical Spine MRI CG | |
2021-ACLA-879 | Brain (Head) MRS CG | 3/3/21 | 4/16/21 | Approved | Brain (Head) MRS CG | |
2021-ACLA-878 | Chest (Thorax) MRI CG | 3/3/21 | 4/16/21 | Approved | Chest (Thorax) MRI CG | |
2021-ACLA-877 | Chest MRA CG | 3/3/21 | 4/16/21 | Approved | Chest MRA CG | |
2021-ACLA-876 | Chest CTA CG | 3/3/21 | 4/16/21 | Approved | Chest CTA CG | |
2021-ACLA-875 | Chest (Thorax) CT CG | 3/3/21 | 4/16/21 | Approved | Chest (Thorax) CT CG | |
2021-ACLA-874 | CT (Virtual) Colonoscopy CG | 3/3/21 | 4/16/21 | Approved | CT (Virtual) Colonoscopy CG | |
2021-ACLA-873 | CT Bone Density Study CG | 3/3/21 | 4/16/21 | Approved | CT Bone Density Study CG | |
2021-ACLA-872 | CT Coronary Angiography (CCTA) CG | 3/3/21 | 4/16/21 | Approved | CT Coronary Angiography (CCTA) CG | |
2021-ACLA-871 | Sinus Face Orbit MRI CG | 3/3/21 | 4/16/21 | Approved | Sinus Face Orbit MRI CG | |
2021-ACLA-870 | Temporal Bone, Mastoid, Orbits, Sella, Internal Auditory Canal CT CG | 3/3/21 | 4/16/21 | Approved | Temporal Bone, Mastoid, Orbits, Sella, Internal Auditory Canal CT CG | |
2021-ACLA-869 | Sinus & Maxillofacial CT Limited or Localized Follow Up Sinus CT CG | 3/3/21 | 4/16/21 | Approved | Sinus & Maxillofacial CT Limited or Localized Follow Up Sinus CT CG | |
2021-ACLA-868 | Spinal Canal MRA CG | 3/3/21 | 4/16/21 | Approved | Spinal Canal MRA CG | |
2021-ACLA-867 | Temporomandibular Joint (TMJ) MRI CG | 3/3/21 | 4/16/21 | Approved | Temporomandibular Joint (TMJ) MRI CG | |
2021-ACLA-866 | Thoracic Spine CT CG | 3/3/21 | 4/16/21 | Approved | Thoracic Spine CT CG | |
2021-ACLA-865 | Upper Extremity CTA/CTV CG | 3/3/21 | 4/16/21 | Approved | Upper Extremity CTA/CTV CG | |
2021-ACLA-864 | Lower Extremity CTA/CTV CG | 3/3/21 | 4/16/21 | Approved | Lower Extremity CTA/CTV CG | |
2021-ACLA-863 | Thoracic Spine MRI CG | 3/3/21 | 4/16/21 | Approved | Thoracic Spine MRI CG | |
2021-ACLA-862 | Upper Extremity CT CG | 3/3/21 | 4/16/21 | Approved | Upper Extremity CT CG | |
2021-ACLA-861 | Breast MRI CG | 3/3/21 | 4/16/21 | Approved | Breast MRI CG | |
2021-ACLA-860 | Ambulatory Surgery Center Procedures CG | 3/3/21 | 4/16/21 | Approved | Ambulatory Surgery Center Procedures CG | |
2021-ACLA-859 | Upper Extremity MRI CG | 3/3/21 | 4/16/21 | Approved | Upper Extremity MRI CG | |
2021-ACLA-858 | Upper Extremity MRA/MRV CG | 3/3/21 | 4/16/21 | Approved | Upper Extremity MRA/MRV CG | |
2021-ACLA-857 | CT Heart, CT Heart Congenital (Not including coronary arteries) CG | 3/3/21 | 4/16/21 | Approved | CT Heart, CT Heart Congenital (Not including coronary arteries) CG | |
2021-ACLA-856 | Functional Brain MRI | 3/2/21 | 4/15/21 | Approved | Functional Brain MRI | |
2021-ACLA-855 | Heart (cardiac) PET | 3/2/21 | 4/15/21 | Approved | Heart (cardiac) PET | |
2021-ACLA-854 | Electron-Beam Tomography CG | 3/2/21 | 4/15/21 | Approved | Electron-Beam Tomography CG | |
2021-ACLA-853 | Heart MRI CG | 3/2/21 | 4/15/21 | Approved | Heart MRI CG | |
2021-ACLA-852 | Heart (cardiac) PET with CT for Attenuation CG | 3/2/21 | 4/15/21 | Approved | Heart (cardiac) PET with CT for Attenuation CG | |
2021-ACLA-851 | Low Dose CT for Lung Cancer Screening CG | 3/2/21 | 4/15/21 | Approved | Low Dose CT for Lung Cancer Screening CG | |
2021-ACLA-850 | Lower Extremity CT CG | 3/2/21 | 4/15/21 | Approved | Lower Extremity CT CG | |
2021-ACLA-849 | Lower Extremity MRA/MRV CG | 3/2/21 | 4/15/21 | Approved | Lower Extremity MRA/MRV CG | |
2021-ACLA-848 | Lower Extremity MRI (foot, ankle, knee, leg, or hip MRI) CG | 3/2/21 | 4/15/21 | Approved | Lower Extremity MRI (foot, ankle, knee, leg, or hip MRI) CG | |
2021-ACLA-847 | Lumbar Spine MRI CG | 3/2/21 | 4/15/21 | Approved | Lumbar Spine MRI CG | |
2021-ACLA-846 | Lumbar Spine CT CG | 3/2/21 | 4/15/21 | Approved | Lumbar Spine CT CG | |
2021-ACLA-845 | Myocardial Perfusion Imaging CG | 3/2/21 | 4/15/21 | Approved | Myocardial Perfusion Imaging CG | |
2021-ACLA-843 | Neck CT CG | 3/2/21 | 4/15/21 | Approved | Neck CT CG | |
2021-ACLA-842 | Multiple Gated Acquisition Scan CG | 3/2/21 | 4/15/21 | Approved | Multiple Gated Acquisition Scan CG | |
2021-ACLA-841 | Neck CTA CG | 3/2/21 | 4/15/21 | Approved | Neck CTA CG | |
2021-ACLA-840 | Neck MRA/MRV CG | 3/2/21 | 4/15/21 | Approved | Neck MRA/MRV CG | |
2021-ACLA-839 | Pelvis CT CG | 3/2/21 | 4/15/21 | Approved | Pelvis CT CG | |
2021-ACLA-838 | Pelvis CT Angiography CG | 3/2/21 | 4/15/21 | Approved | Pelvis CT Angiography CG | |
2021-ACLA-837 | Pelvis MRA CG | 3/2/21 | 4/15/21 | Approved | Pelvis MRA CG | |
2021-ACLA-836 | Pelvis MRI CG | 3/2/21 | 4/15/21 | Approved | Pelvis MRI CG | |
2020-UHC-788 | Mechanical Stretching Devices | 3/1/21 | 4/14/21 | Approved | Mechanical Stretching Devices | |
2020-UHC-785 | Hearing Aids Devices | 3/1/21 | 4/14/21 | Approved | Hearing Aids Devices | |
2020-LHCC-681 | Claims Payment Reporting and Auditing | 3/1/21 | 4/14/21 | Approved | Claims Payment Reporting and Auditing | |
2020-LHCC-680 | Provider Reimbursement | 3/1/21 | 4/14/21 | Approved | Provider Reimbursement | |
2020-LHCC-635 | COB TPL TB | 3/1/21 | 4/14/21 | Approved | COB TPL TB | |
2020-HBL-586 | Global Surgical Package Reimbursement | 3/1/21 | 4/14/21 | Approved | Global Surgical Package Reimbursement | |
2020-HBL-472 | Women’s Health and Family Planning | 3/1/21 | 4/14/21 | Approved | Women’s Health and Family Planning | |
2021-LDH-2 | LDH MCO Manual Part 9: Third Party Liability | 2/24/21 | 4/10/21 | Pending | LDH MCO Manual Part 9: Third Party Liability | |
2021-LDH-1 | LDH MCO Manual Part 4: Services > Professional Services > "Incident to" Services | 2/24/21 | 4/10/21 | Pending | LDH MCO Manual Part 4: Services > Professional Services > "Incident to" Services | |
2021-TPL-1 | Cost avoidance and pay and chase policy changes for third party liability relative to prenatal, labor and delivery, and postpartum care, for child support enforcement cases, and for preventative pediatric services | 2/12/21 | 3/29/2021 | Pending | HPA 21-XX Pay and Chase Updates for BBA Compliance IB 21-XX Pay and Chase Updates for BBA Compliance Diagnosis Codes Related to Prenatal Services [referenced in above HPA and IB] Wait and See Provider Notice [referenced in above IB] HPA 16-17 Pay and Chase, revised Primary Preventive Pediatric Care Diagnosis Codes [referenced in HPA 16-17 revision] |
|
2021-UHC-825 | Cardiac Event Monitoring | 2/5/21 | 3/21/21 | Approved | Cardiac Event Monitoring | |
2021-UHC-826 | Elbow Replacement Surgery (Arthroplasty) | 2/5/21 | 3/21/21 | Approved | Elbow Replacement Surgery (Arthroplasty) | |
2021-UHC-827 | Protherapy Musculoskeletal Indications | 2/5/21 | 3/21/21 | Approved | Protherapy Musculoskeletal Indications | |
2021-UHC-828 | Surgical Treatment for Spine Pain | 2/5/21 | 3/21/21 | Approved | Surgical Treatment for Spine Pain | |
2020-HBL-589 | Non-covered and Cost Effective Alternative Services | 3/1/21 | 4/14/21 | MCO Withdrawn | Non-covered and Cost Effective Alternative Services | |
2020-HBL-250 | Revised Provider Manual | 3/1/21 | 4/14/21 | MCO Withdrawn | Revised Provider Manual |
Medicaid Managed Care Policies & Procedures Archive (2021)
"Policy or procedure" shall mean a requirement governing the administration of managed care organizations specific to billing guidelines, medical management and utilization review guidelines, case management guidelines, claims processing guidelines and edits, grievance and appeals procedures and process, other guidelines or manuals containing pertinent information related to operations and pre-processing claims, and core benefits and services.
Below are items previously posted for public comment:
RELATED INFO